JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R. E.
Right arrow Articles by Morrill, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R. E.
Right arrow Articles by Morrill, M. J.

Journal of the American Podiatric Medical Association, Vol 81, Issue 5 253-257, Copyright © 1991 by American Podiatric Medical Association

JOURNAL ARTICLE

Recombinant alpha-interferon and verruca plantaris. A review of the literature

RE Johnson, JC Johnson, SJ Kloberdanz and MJ Morrill
College of Podiatric Medicine and Surgery, University of Osteopathic Medicine and Health Sciences, Des Moines, IA 50312.

The authors review the literature and report the mechanisms of action, chemical properties, pharmacokinetics, adverse effects, and clinical studies of recombinant alpha-interferon. The authors believe that clinical trials should be performed with recombinant alpha-interferon therapy on verruca plantaris to prove or disprove the effectiveness of interferon as a potential treatment modality for these commonly encountered lesions.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Podiatric Medical Association.